Crossmark Global Holdings’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $242K | Buy |
|
|||||
|
2025
Q1 | $235K | Buy |
|
|||||
|
2024
Q4 | $277K | Sell |
|
|||||
|
2024
Q3 | $411K | Sell |
|
|||||
|
2024
Q2 | $498K | Buy |
|
|||||
|
2024
Q1 | $597K | Sell |
|
|||||
|
2023
Q4 | $606K | Sell |
|
|||||
|
2023
Q3 | $696K | Buy |
|
|||||
|
2023
Q2 | $786K | Sell |
|
|||||
|
2023
Q1 | $1.04M | Sell |
|
|||||
|
2022
Q4 | $1.02M | Buy |
|
|||||
|
2022
Q3 | $859K | Sell |
|
|||||
|
2022
Q2 | $1.08M | Buy |
|
|||||
|
2022
Q1 | $1.07M | Sell |
|
|||||
|
2021
Q4 | $1.55M | Sell |
|
|||||
|
2021
Q3 | $3.51M | Sell |
|
|||||
|
2021
Q2 | $3.26M | Sell |
|
|||||
|
2021
Q1 | $2.97M | Sell |
|
|||||
|
2020
Q4 | $3.5M | Buy |
|
|||||
|
2020
Q3 | $1.26M | Buy |
|
|||||
|
2020
Q2 | $922K | Buy |
|
|||||
|
2020
Q1 | $640K | Sell |
|
|||||
|
2019
Q4 | $701K | Sell |
|
|||||
|
2019
Q3 | $764K | Sell |
|
|||||
|
2019
Q2 | $750K | Sell |
|
|||||
|
2019
Q1 | $777K | Buy |
|
|||||
|
2018
Q4 | $565K | Sell |
|
|||||
|
2018
Q3 | $887K | Sell |
|
|||||
|
2018
Q2 | $862K | Sell |
|
|||||
|
2018
Q1 | $795K | Sell |
|
|||||
|
2017
Q4 | $857K | Sell |
|
|||||
|
2017
Q3 | $897K | Buy |
|
|||||
|
2016
Q3 | $897K | Buy |
|